TRXB stock news today

Evercore ISI starts Trex Bio coverage with Outperform rating and $28 price target

Evercore ISI Group began covering Trex Bio and gave the shares an Outperform rating. The firm set a $28 price target on the stock.

JP Morgan starts Trex Bio coverage with Overweight rating and $20 price target

JP Morgan began covering Trex Bio and rated the shares Overweight. The firm set a $20 price target on the stock.

Cantor Fitzgerald starts Trex Bio coverage with Overweight rating

Cantor Fitzgerald began covering Trex Bio and gave the shares an Overweight rating. The call is an analyst opinion on the stock.

Stifel starts Trex Bio coverage with Buy rating and $39 price target

Stifel began covering Trex Bio with a Buy rating and set a $39 price target on the shares. The call reflects the analyst's positive view of the company.

Wedbush starts Trex Bio coverage with Outperform rating and $30 price target

Wedbush began covering Trex Bio, giving the shares an Outperform rating and setting a $30 price target. The call is an analyst view on the stock rather than company news.

Eli Lilly acquires 5.48M shares of TRex Bio for $12.3M in IPO

Eli Lilly now holds a 19.9% ownership position in TRex Bio after purchasing 5.48 million shares. The $12.3 million purchase was made as part of TRex Bio's initial public offering.

Form 4 reports shares bought or sold by company insiders such as officers, directors or large holders.

What is the latest news on TRXB?

Nov 3, 2026: Evercore ISI starts Trex Bio coverage with Outperform rating and $28 price target (Benzinga) · Nov 3, 2026: JP Morgan starts Trex Bio coverage with Overweight rating and $20 price target (Benzinga) · Nov 3, 2026: Cantor Fitzgerald starts Trex Bio coverage with Overweight rating (Benzinga)

What has TRXB filed with the SEC recently?

Oct 15, 2026: TRex Bio, Inc. filed an insider trading report (Form 4)